235 related articles for article (PubMed ID: 9588884)
1. The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.
Barillari G; Albonici L; Franzese O; Modesti A; Liberati F; Barillari P; Ensoli B; Manzari V; Santeusanio G
Am J Pathol; 1998 May; 152(5):1161-6. PubMed ID: 9588884
[TBL] [Abstract][Full Text] [Related]
2. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
Ziche M; Maglione D; Ribatti D; Morbidelli L; Lago CT; Battisti M; Paoletti I; Barra A; Tucci M; Parise G; Vincenti V; Granger HJ; Viglietto G; Persico MG
Lab Invest; 1997 Apr; 76(4):517-31. PubMed ID: 9111514
[TBL] [Abstract][Full Text] [Related]
3. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park JE; Chen HH; Winer J; Houck KA; Ferrara N
J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
[TBL] [Abstract][Full Text] [Related]
4. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
5. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
6. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.
Viglietto G; Romano A; Maglione D; Rambaldi M; Paoletti I; Lago CT; Califano D; Monaco C; Mineo A; Santelli G; Manzo G; Botti G; Chiappetta G; Persico MG
Oncogene; 1996 Aug; 13(3):577-87. PubMed ID: 8760299
[TBL] [Abstract][Full Text] [Related]
7. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.
Takahashi A; Sasaki H; Kim SJ; Tobisu K; Kakizoe T; Tsukamoto T; Kumamoto Y; Sugimura T; Terada M
Cancer Res; 1994 Aug; 54(15):4233-7. PubMed ID: 7518352
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
12. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor.
Cao Y; Linden P; Shima D; Browne F; Folkman J
J Clin Invest; 1996 Dec; 98(11):2507-11. PubMed ID: 8958213
[TBL] [Abstract][Full Text] [Related]
13. Placenta growth factor (PlGF) mRNA expression in brain tumors.
Nomura M; Yamagishi S; Harada S; Yamashima T; Yamashita J; Yamamoto H
J Neurooncol; 1998 Nov; 40(2):123-30. PubMed ID: 9892094
[TBL] [Abstract][Full Text] [Related]
14. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
15. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
Monsky WL; Fukumura D; Gohongi T; Ancukiewcz M; Weich HA; Torchilin VP; Yuan F; Jain RK
Cancer Res; 1999 Aug; 59(16):4129-35. PubMed ID: 10463618
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer].
Ogura Y; Sato K; Kato T; Saito K; Enomoto K
Nihon Hinyokika Gakkai Zasshi; 1998 May; 89(5):529-37. PubMed ID: 9642990
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor.
Birkenhäger R; Schneppe B; Röckl W; Wilting J; Weich HA; McCarthy JE
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):703-7. PubMed ID: 8670141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]